You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 115 No. 4, April 1979 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (9)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Topical Methoxsalen Administration and Sunlamp Fluorescent Irradiation in Psoriasis

John W. Petrozzi, MD; John O. Barton; Albert Kligman, MD

Arch Dermatol. 1979;115(4):436-439.


Abstract

Analysis of standard fluorescent sunlamps (Westinghouse) indicates that in addition to UVB (290 to 320 nm), a considerable amount of UVA (320 to 400 nm) is also present in their emissions. Since the benefits of topical psoralen administration and UVA have already been demonstrated, and prior experience by ourselves and others with UVB has indicated that some psoriasis benefited from UVB alone, localized areas and plaques of 20 patients were treated with topical administration of psoralens and fluorescent sunlamp bulbs to determine if such a light source with this emission spectrum would be advantageous. Results indicated a total resolution in 17 of 20 patients after an average of 18 treatments. Adverse blistering phototoxic reactions and excessive hyperpigmentation were not encountered. The UVB erythema response of normal skin served as the guide to light dosage in the same manner as administration of the Goeckerman regimen. Therefore, the use of psoralens was very effective when combined with fluorescent sunlamp irradiation; however, the potential risks of photocarcinogenicity makes this treatment experimental and should be reserved for recalcitrant cases.

(Arch Dermatol 115:436-439, 1979)



Author Affiliations

Octavio de los Reyes

From the Department of Dermatology, University of Pennsylvania School of Medicine, Philadelphia, and the Philadelphia Veterans Administration Hospital.


Footnotes

Accepted for publication Oct 27, 1978.

Reprint requests to Department of Dermatology (111-P), Philadelphia Veterans Administration Hospital, University and Woodland Avenues, Philadelphia, PA 19104 (Dr Petrozzi).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Treatment of Palmoplantar Psoriasis With Topical Methoxsalen Plus Long-Wave Ultraviolet Light
Abel et al.
Arch Dermatol 1980;116:1257-1261.
ABSTRACT  

Comparison of Crude Coal Tar and Topical Methoxsalen in Treatment of Psoriasis
Petrozzi and Barton
Arch Dermatol 1979;115:1061-1063.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1979 American Medical Association. All Rights Reserved.